P98088 (MUC5A_HUMAN) Homo sapiens (Human)

Mucin-5AC UniProtKBInterProSTRINGInteractive Modelling

5654 aa; Sequence (Fasta)

Sequence Features

Add
 5521P -> L (in dbSNP:rs1132436) VAR_036832 dbSNP
 4926-4927Cleavage
 103-111
 456-464
 5532-5582
 5546-5596
 5557-5612
 5561-5614
 81-218von Willebrand factor, type D domain
IPR001846PF00094
 266-334Uncharacterised domain, cysteine-rich
IPR014853PF08742
 338-394Trypsin Inhibitor-like, cysteine rich domain
IPR002919PF01826
 434-587von Willebrand factor, type D domain
IPR001846PF00094
 630-694Uncharacterised domain, cysteine-rich
IPR014853PF08742
 704-761Trypsin Inhibitor-like, cysteine rich domain
IPR002919PF01826
 903-1051von Willebrand factor, type D domain
IPR001846PF00094
 1094-1161Uncharacterised domain, cysteine-rich
IPR014853PF08742
 1389-1475WxxW domain
IPR025155PF13330
 1584-1670WxxW domain
IPR025155PF13330
 1749-1840WxxW domain
IPR025155PF13330
 1957-2043WxxW domain
IPR025155PF13330
 2122-2213WxxW domain
IPR025155PF13330
 3228-3319WxxW domain
IPR025155PF13330
 3526-3617WxxW domain
IPR025155PF13330
 3959-4050WxxW domain
IPR025155PF13330
 4633-4724WxxW domain
IPR025155PF13330
 4921-5080von Willebrand factor, type D domain
IPR001846PF00094
 5146-5208Uncharacterised domain, cysteine-rich
IPR014853PF08742

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
Crystal structure of the inactive form of GalNAc-T2 in complex with the glycopeptide MUC5AC-3,13 Heteromer
Q10471;
A2G; 31×SO4;5ajo4566-4580
Assess
Crystal structure of the inactive form of GalNAc-T2 in complex with the glycopeptide MUC5AC-Cys13 Heteromer
Q10471;
12×SO4; 14×EDO;A2G;5ajn4566-4580
Assess
Crystal structure of the active form of GalNAc-T2 in complex with UDP and the glycopeptide MUC5AC-13 Heteromer
Q10471;
UDP; 21×SO4;MN;A2G;5ajp4567-4580
Assess

Homology models

Oligo-stateQMEANTemplateRangeSeq id (%)Ligands
monomer -2.55 6n29.2.A802-1268
39.47CA;
Assess
monomer -1.22 6tm2.1.E1386-1478
41.80
Assess
monomer -2.90 7a5o.1.A79-1245
51.48
Assess
monomer -3.29 6tm2.1.E3225-3322
40.63
Assess
monomer -3.69 7kwo.1.B802-1275
36.11CA;
Assess
monomer -3.06 6tm6.1.A2118-2220
43.01
Assess
monomer -2.22 6tm6.1.A3955-4057
43.01
Assess
monomer -4.35 6n29.1.A81-432
34.31
Assess
monomer -4.83 6rbf.1.A81-419
33.54
Assess